These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 3947534)

  • 21. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
    Chang H; Han B; Han XZ
    Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
    Zhang H; Yousef GE; Ouyang X; Archard LC
    Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage.
    Chow LH; Gauntt CJ; McManus BM
    Lab Invest; 1991 Jan; 64(1):55-64. PubMed ID: 1990209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arrhythmias in Coxsackie B3 virus myocarditis. Continuous electrocardiography in conscious mice and histopathology of the heart with special reference to the conduction system.
    Terasaki F; Kitaura Y; Hayashi T; Nakayama Y; Deguchi H; Kawamura K
    Heart Vessels Suppl; 1990; 5():45-50. PubMed ID: 1965542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
    Shen Y; Kan QC; Xu W; Chu YW; Xiong SD
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of cyclosporine on acute murine Coxsackie B3 myocarditis.
    O'Connell JB; Reap EA; Robinson JA
    Circulation; 1986 Feb; 73(2):353-9. PubMed ID: 3943167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice.
    Lane JR; Neumann DA; Lafond-Walker A; Herskowitz A; Rose NR
    J Exp Med; 1992 Apr; 175(4):1123-9. PubMed ID: 1552283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice.
    Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
    Cardiovasc Res; 1992 Oct; 26(10):956-61. PubMed ID: 1336713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of murine coxsackie B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leucocyte interferon alpha A/D.
    Kishimoto C; Crumpacker CS; Abelmann WH
    Cardiovasc Res; 1988 Oct; 22(10):732-8. PubMed ID: 2855719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coxsackie virus B3 perimyocarditis in BALB/c mice: experimental model of chronic perimyocarditis in the right ventricle.
    Matsumori A; Kawai C
    J Pathol; 1980 Jun; 131(2):97-106. PubMed ID: 6253611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of subsequent myocardial damage on the expression of coxsackievirus B4 myocarditis and the development of ventricular aneurysms.
    Khatib R; Khatib G; Reyes MP; Giraldo A
    Eur Heart J; 1994 Aug; 15(8):1140-3. PubMed ID: 7988609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal changes in stem cells in the circulation and myocardium of mice with Coxsackie virus B3-induced myocarditis.
    Zhao L; Li S; Ge J; Sun A; Zou Y; Zhang S
    Microvasc Res; 2008 Apr; 75(3):358-66. PubMed ID: 18206181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart muscle performance after experimental viral myocarditis.
    Adesanya CO; Goldberg AH; Phear WP; Thorp KA; Young NA; Abelmann WH
    J Clin Invest; 1976 Mar; 57(3):569-75. PubMed ID: 1249200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in virulence of Coxsackie virus B3 in the heart of mice, II. Pathological comparison.
    Hashimoto I; Komatsu T; Kohara T
    Microbiol Immunol; 1983; 27(4):335-45. PubMed ID: 6310354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of coxsackievirus B3 myocarditis by immunoactive peptide in an animal model.
    Sato Y; Matsumori A
    Clin Immunol Immunopathol; 1992 Oct; 65(1):65-9. PubMed ID: 1395125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological and pathological observations on experimental coxsackie B-3 viral myocarditis in mice.
    Yang YZ; Guo Q; Zhou TS; Zhang J; Li L; Jin PY; Wu WZ; Shen JY; Yang JH; Peng BZ
    Chin Med J (Engl); 1993 Feb; 106(2):100-4. PubMed ID: 8389271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine natural killer cells limit coxsackievirus B3 replication.
    Godeny EK; Gauntt CJ
    J Immunol; 1987 Aug; 139(3):913-8. PubMed ID: 3036947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine myocarditis due to coxsackie B 3 virus: blood amino acid, virologic, and histopathologic correlates.
    Feigin RD; Middelkamp JN; Reed CA
    J Infect Dis; 1972 Dec; 126(6):574-84. PubMed ID: 4664114
    [No Abstract]   [Full Text] [Related]  

  • 39. Exercise in coxsackie B3 myocarditis: effects on heart lymphocyte subpopulations and the inflammatory reaction.
    Ilbäck NG; Fohlman J; Friman G
    Am Heart J; 1989 Jun; 117(6):1298-302. PubMed ID: 2543197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of viral RNA in experimental coxsackievirus B3 myocarditis of mice using the polymerase chain reaction.
    Okada I; Matsumori A; Kyu B
    Int J Exp Pathol; 1992 Dec; 73(6):721-31. PubMed ID: 1337265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.